eFFECTOR Therapeutics (EFTR) Short Interest Ratio & Short Volume

$0.05

0.00 (0.00%)

(As of 07/26/2024 ET)

Compare

eFFECTOR Therapeutics Short Interest Data

Current Short Interest: 687,000 shares
Previous Short Interest: 91,600 shares
Change Vs. Previous Month: +650.00%
Dollar Volume Sold Short: $199,298.70
Short Interest Ratio: 1.1 Days to Cover
Last Record Date: June 30, 2024

Outstanding Shares: 4,704,000 shares
Float Size: 4,080,000 shares
Short Percent of Float: 16.84%
Today's Trading Volume: 24,737 shares
Average Trading Volume: 452,466 shares
Today's Volume Vs. Average: 5%

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Short Selling eFFECTOR Therapeutics ?

Sign up to receive the latest short interest report for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

EFTR Short Interest Over Time

EFTR Days to Cover Over Time

EFTR Percentage of Float Shorted Over Time

Ad Behind the Markets

J.P. Morgan’s DIRE Warning

When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."

Click here to see why Wall Street is in PANIC mode >>>

eFFECTOR Therapeutics Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
6/30/2024	687,000 shares	$199,298.70	+650.0%	16.8%	1.1	$0.29
6/15/2024	91,600 shares	$114,500.00	-3.3%	2.3%	0.1	$1.25
5/31/2024	94,700 shares	$151,520.00	-14.5%	2.4%	0.3	$1.60
5/15/2024	110,700 shares	$219,186.00	-13.7%	2.9%	0.3	$1.98
4/30/2024	128,300 shares	$288,675.00	-47.4%	3.1%	0.3	$2.25
4/15/2024	244,000 shares	$470,920.00	-29.3%	7.2%	0.7	$1.93
Get the Latest News and Ratings for EFTR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
3/31/2024	345,200 shares	$4.97 million	+8.5%	10.7%	1	$14.39
3/15/2024	318,100 shares	$3.52 million	+43.1%	15.0%	2.2	$11.06
2/29/2024	222,300 shares	$3.21 million	+113.8%	10.5%	1.6	$14.44
2/15/2024	104,000 shares	$1.21 million	-4.4%	4.9%	0.9	$11.66
1/31/2024	108,800 shares	$1.25 million	-12.6%	5.9%	1	$11.47
1/15/2024	124,500 shares	$1.33 million	-85.0%	6.7%	1.3	$10.69
12/31/2023	827,900 shares	$386,960.46	-21.9%	1.8%	0.4	$0.47
12/15/2023	1,060,000 shares	$398,348.00	+1.0%	2.3%	0.6	$0.38
11/30/2023	1,050,000 shares	$556,920.00	+141.9%	2.3%	0.8	$0.53
11/15/2023	434,000 shares	$253,890.00	+72.8%	1.0%	0.6	$0.59
10/31/2023	251,100 shares	$135,594.00	-50.5%	0.7%	0.6	$0.54
10/15/2023	507,600 shares	$291,057.84	+133.9%	1.3%	1.1	$0.57
9/30/2023	217,000 shares	$130,178.30	-74.0%	0.6%	0.5	$0.60
9/15/2023	834,100 shares	$508,801.00	-8.5%	2.2%	1.4	$0.61
8/31/2023	912,000 shares	$663,936.00	+36.7%	2.4%	1	$0.73
8/15/2023	667,400 shares	$453,231.34	-38.8%	1.7%	0.3	$0.68
7/31/2023	1,090,000 shares	$881,156.00	-15.5%	3.6%	0.5	$0.81
7/15/2023	1,290,000 shares	$990,720.00	+219.3%	4.2%	0.6	$0.77
6/30/2023	404,000 shares	$335,400.80	+91.4%	1.4%	0.2	$0.83
6/15/2023	211,100 shares	$197,378.50	-83.0%	0.8%	0.1	$0.94
5/31/2023	1,240,000 shares	$1.15 million	+1,506.2%	4.6%	0.8	$0.93
5/15/2023	77,200 shares	$52,874.28	-12.6%	0.4%	0.4	$0.68
4/30/2023	88,300 shares	$41,501.00	-32.5%	0.6%	0.5	$0.47
4/15/2023	130,800 shares	$50,358.00	+236.3%	0.7%	0.7	$0.39
3/31/2023	38,900 shares	$13,720.03	-45.2%	0.1%	0.2	$0.35
3/15/2023	71,000 shares	$28,400.00	+110.7%	0.2%	0.2	$0.40
2/28/2023	33,700 shares	$16,789.34	-72.2%	0.3%	0.1	$0.50
2/15/2023	121,300 shares	$72,780.00	-9.1%	0.9%	0.4	$0.60
1/31/2023	133,400 shares	$68,447.54	-29.3%	1.0%	0.4	$0.51
1/15/2023	188,800 shares	$84,960.00	+56.4%	1.4%	0.7	$0.45
12/30/2022	120,700 shares	$51,611.32	+148.9%	0.9%	0.5	$0.43
12/15/2022	48,500 shares	$19,400.00	+41.4%	0.4%	0.5	$0.40
11/30/2022	34,300 shares	$14,399.14	-49.9%	0.3%	0.3	$0.42
11/15/2022	68,400 shares	$37,695.24	-51.7%	0.5%	0.5	$0.55
Nvidia insiders dumping shares (Ad) All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can. To see Porter Stansberry's new AI prediction go here now.
10/31/2022	141,600 shares	$86,758.32	+13.2%	1.1%	0.1	$0.61
10/15/2022	125,100 shares	$73,296.09	-42.5%	1.0%	0.1	$0.59
9/30/2022	217,500 shares	$124,431.75	+55.0%	1.7%	0.2	$0.57
9/15/2022	140,300 shares	$83,071.63	-25.5%	1.1%	0.1	$0.59
8/31/2022	188,300 shares	$114,768.85	+21.5%	1.4%	0.2	$0.61
8/15/2022	155,000 shares	$111,026.50	+104.8%	1.3%	0.1	$0.72
7/31/2022	75,700 shares	$61,301.86	-19.5%	1.0%	0.1	$0.81
7/15/2022	94,000 shares	$105,280.00	-30.4%	1.2%	1.5	$1.12
6/30/2022	135,000 shares	$191,700.00	-12.0%	1.8%	3.1	$1.42
6/15/2022	153,400 shares	$225,498.00	-13.2%	2.0%	4	$1.47
5/31/2022	176,700 shares	$381,672.00	+0.8%	2.3%	5.2	$2.16
5/15/2022	175,300 shares	$315,540.00	-26.2%	2.3%	6.7	$1.80
4/30/2022	237,400 shares	$790,542.00	-1.7%	3.2%	8.1	$3.33
4/15/2022	241,600 shares	$850,432.00	-3.4%	3.2%	7.9	$3.52
3/31/2022	250,000 shares	$1.00 million	-6.6%	N/A	7.7	$4.01
3/15/2022	267,700 shares	$1.07 million	-11.7%	3.8%	4.5	$4.00
2/28/2022	303,100 shares	$1.41 million	-6.2%	4.6%	3.2	$4.65
2/15/2022	323,200 shares	$1.49 million	-2.4%	N/A	3	$4.61
1/31/2022	331,300 shares	$1.87 million	-5.3%	5.1%	2.7	$5.65
1/15/2022	350,000 shares	$2.54 million	-5.9%	N/A	2.7	$7.25
12/31/2021	372,100 shares	$3.08 million	No Change	5.0%	1.9	$8.28

EFTR Short Interest - Frequently Asked Questions

What is eFFECTOR Therapeutics' current short interest?: Short interest is the volume of eFFECTOR Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 687,000 shares of EFTR short. 16.84% of eFFECTOR Therapeutics' shares are currently sold short. Learn More on eFFECTOR Therapeutics' current short interest.
What is a good short interest ratio for eFFECTOR Therapeutics?: The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EFTR shares currently have a short interest ratio of 1.0. Learn More on eFFECTOR Therapeutics's short interest ratio.
What is a good short interest percentage for eFFECTOR Therapeutics?: Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.84% of eFFECTOR Therapeutics' floating shares are currently sold short.
Is eFFECTOR Therapeutics' short interest increasing or decreasing?: eFFECTOR Therapeutics saw a increase in short interest in June. As of June 30th, there was short interest totaling 687,000 shares, an increase of 650.0% from the previous total of 91,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
What is eFFECTOR Therapeutics' float size?: eFFECTOR Therapeutics currently has issued a total of 4,700,000 shares. Some of eFFECTOR Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. eFFECTOR Therapeutics currently has a public float of 4,080,000 shares.

How does eFFECTOR Therapeutics' short interest compare to its competitors?: 16.84% of eFFECTOR Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to eFFECTOR Therapeutics: Biodexa Pharmaceuticals Plc (45.71%), Akanda Corp. (4.57%), Lucy Scientific Discovery Inc. (0.24%), Mainz Biomed (4.79%), NLS Pharmaceutics Ltd. (1.91%), SNDL Inc. (4.15%), Owlet, Inc. (6.52%), Mondee Holdings, Inc. (12.21%), Novo Nordisk A/S (0.07%), AstraZeneca PLC (0.19%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks.
What does it mean to sell short eFFECTOR Therapeutics stock?: Short selling EFTR is an investing strategy that aims to generate trading profit from eFFECTOR Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against eFFECTOR Therapeutics?: A short squeeze for eFFECTOR Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EFTR, which in turn drives the price of the stock up even further.
How often is eFFECTOR Therapeutics' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EFTR, twice per month. The most recent reporting period available is June, 30 2024.